chitosan has been researched along with Newcastle Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S; Jin, Z; Liu, J; Zhao, K | 1 |
| Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Yang, Y; Yu, H | 1 |
| Hu, G; Jin, Z; Shi, C; Sun, B; Sun, Y; Zhao, K | 1 |
| Cheng, G; Dai, C; Jin, Z; Li, D; Wang, X; Zhao, K | 1 |
| Duan, X; Han, J; Jin, Z; Li, S; Li, W; Wang, X; Yu, L; Zhao, K | 1 |
| Han, J; Jin, Z; Wang, X; Wang, Y; Wei, L; Yu, S; Zhang, Y; Zhao, K | 1 |
| He, X; Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Yu, H | 1 |
| Chen, Q; Cui, H; Dai, C; Guo, C; Jin, Z; Li, W; Shi, C; Wang, Y; Zhang, X; Zhang, Y; Zhao, K; Zhao, Y | 1 |
| Chvala, IA; Drygin, VV; Frolov, SF; Irza, AV; Kapczynski, DR; Volkova, MA | 1 |
| Cui, S; Jin, Z; Shi, C; Wang, X; Zhang, X; Zhang, Y; Zhao, K | 1 |
| Cheng, G; Dai, C; Jin, Z; Kang, H; Liu, C; Rong, G; Sun, J; Wang, X; Yang, W; Zhao, K | 1 |
| He, X; Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Yu, H; Zou, P | 1 |
| Anbari, S; Boschmans, M; Gardin, Y; Lambrecht, B; Lemaire, S; Palya, V; Rauw, F; van den Berg, T | 1 |
| Anbari, S; Gardin, Y; Gonze, M; Lambrecht, B; Lemaire, S; Palya, V; Rauw, F; van den Berg, T | 1 |
| Bu, Z; Liu, N; Wang, J; Wu, D; Yang, T; Yin, Z; Zhang, W | 1 |
| Chen, JD; Dong, XY; Hu, YM; Jan, SS; Liu, DC | 1 |
| Chen, G; Cui, X; Gao, TT; Li, W; Shi, XM; Wang, YF; Wu, J; Zhang, FQ; Zhao, K; Zhao, Y | 1 |
| Jiang, SJ; Qin, ZM; Wang, YL; Xu, HY; Zhai, RL | 1 |
| Chen, CT; Mi, FL; Schoung, JY; Shyu, SS | 1 |
1 trial(s) available for chitosan and Newcastle Disease
| Article | Year |
|---|---|
Adjuvant effects of chitosan and calcium phosphate particles in an inactivated Newcastle disease vaccine.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Calcium Phosphates; Chickens; Chitosan; Female; Immunity, Humoral; Immunity, Mucosal; Newcastle Disease; Newcastle disease virus; Poultry Diseases; Viral Vaccines | 2014 |
18 other study(ies) available for chitosan and Newcastle Disease
| Article | Year |
|---|---|
Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.
Topics: Adjuvants, Immunologic; Aluminum; Animals; Chickens; Chitosan; Immunity, Cellular; Influenza A Virus, H9N2 Subtype; Nanoparticles; Newcastle Disease; Newcastle disease virus; Vaccines, Inactivated | 2023 |
Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine.
Topics: Adjuvants, Immunologic; Animals; Chickens; Chitosan; Cytokines; Immunity, Humoral; Lymphocytes; Mice; Nanoparticles; Newcastle Disease; Newcastle disease virus; Poultry Diseases; Quaternary Ammonium Compounds; RAW 264.7 Cells; Vaccination; Vaccines, Inactivated; Viral Vaccines | 2020 |
Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
Topics: Adjuvants, Vaccine; Administration, Intranasal; Ammonium Chloride; Animals; Chickens; Chitosan; Immunity, Mucosal; Immunization; Newcastle Disease; Newcastle disease virus; Particle Size; Vaccination; Vaccines, DNA; Viral Vaccines | 2021 |
Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles.
Topics: Ammonium Chloride; Animals; Chickens; Chitosan; Immunity, Mucosal; Nanoparticles; Newcastle Disease; Newcastle disease virus; Specific Pathogen-Free Organisms; Vaccines, Attenuated; Viral Vaccines | 2017 |
Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration.
Topics: Administration, Intranasal; Animals; Chickens; Chitosan; Coronavirus Infections; Immunoglobulin A; Immunoglobulin G; Infectious bronchitis virus; Interferon-gamma; Interleukins; Nanoparticles; Newcastle Disease; Vaccines, Attenuated | 2017 |
Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
Topics: Animals; Cell Proliferation; Chickens; Chitosan; Drug Carriers; Immunity, Mucosal; Interferon-gamma; Interleukin-2; Interleukin-4; Newcastle Disease; Newcastle disease virus; Vaccines, DNA | 2018 |
The improved antiviral activities of amino-modified chitosan derivatives on Newcastle virus.
Topics: Amines; Animals; Antiviral Agents; Chickens; Chitosan; Eggs; Hemagglutination Tests; Molecular Weight; Newcastle Disease; Newcastle disease virus; Solubility | 2021 |
Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.
Topics: Animals; Chickens; Chitosan; DNA, Viral; HEK293 Cells; Humans; Nanocapsules; Newcastle Disease; Newcastle disease virus; Survival Rate; Treatment Outcome; Vaccines, DNA | 2014 |
Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
Topics: Animals; Chickens; Chitosan; DNA, Viral; Drug Carriers; Immunoglobulin A; Lactic Acid; Lymphocytes; Nanoparticles; Newcastle Disease; Newcastle disease virus; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tears; Vaccines, DNA | 2014 |
O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
Topics: Animals; Cells, Cultured; Chickens; Chitosan; Cytokines; Drug Carriers; Drug Delivery Systems; Microscopy, Electron, Transmission; Nanoparticles; Newcastle Disease; Newcastle disease virus; Poultry Diseases; Proton Magnetic Resonance Spectroscopy; Quaternary Ammonium Compounds; Spectroscopy, Fourier Transform Infrared; Vaccination; Viral Vaccines; X-Ray Diffraction | 2015 |
Beta-chitosan extracted from Loligo Japonica for a potential use to inhibit Newcastle disease.
Topics: Animals; Antiviral Agents; Chick Embryo; Chitosan; Loligo; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Newcastle Disease; Newcastle disease virus; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chickens; Chitosan; Cloaca; Genetic Vectors; Herpesvirus 1, Meleagrid; Newcastle Disease; Ovum; Spleen; Survival Analysis; T-Lymphocytes; Vaccination; Vaccines, Attenuated; Vaccines, Synthetic; Viral Fusion Proteins; Viral Vaccines; Virus Shedding | 2010 |
The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.
Topics: Adjuvants, Immunologic; Animals; Chickens; Chitosan; Duodenum; Humans; Immunity, Cellular; Immunity, Humoral; Lymphocytes; Mice; Newcastle Disease; Newcastle disease virus; Spleen; Viral Vaccines | 2010 |
DNA-chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene.
Topics: Adjuvants, Immunologic; Animals; Cell Line; Cell Survival; Chickens; Chitosan; Deoxyribonuclease I; DNA; Endocytosis; Enzyme-Linked Immunosorbent Assay; Hemagglutination Inhibition Tests; Immunization; Interferon-gamma; Interleukin-2; Nanoparticles; Newcastle Disease; Newcastle disease virus; Plasmids; Transfection; Vaccines, DNA; Viral Vaccines | 2010 |
Effects of chitosan and its derivative added to water on immunological enhancement and disease control.
Topics: Animal Feed; Animals; Antibody Formation; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chickens; Chitosan; Cytokines; Diarrhea; Humans; Immunization; Immunologic Factors; Lymphocyte Activation; Newcastle Disease; Water | 2012 |
Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.
Topics: Animals; Cells, Cultured; Chick Embryo; Chickens; Chitosan; Drug Compounding; Nanoparticles; Newcastle Disease; Newcastle disease virus; Poultry Diseases; Random Allocation; Treatment Outcome; Vaccination; Vaccines, Attenuated; Viral Vaccines | 2012 |
[Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
Topics: Animals; Antibodies, Viral; Chickens; Chitosan; Immunoglobulin A, Secretory; Immunoglobulin G; Microspheres; Newcastle Disease; Newcastle disease virus; Poultry Diseases; Random Allocation; Vaccination; Viral Vaccines | 2007 |
Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release.
Topics: Adsorption; Antigens, Viral; Biocompatible Materials; Chitin; Chitosan; Diffusion; Drug Delivery Systems; Hydrolysis; Microscopy, Electron, Scanning; Microspheres; Newcastle Disease; Newcastle disease virus; Vaccines, Inactivated | 1999 |